#biotech

🏢Release 📈 Stocks

GPN Vaccines Secures US$10 Million to Advance Gamma-PN Phase 2 Trials

November 2, 2026 (8 days ago)

Clinical-stage firm GPN Vaccines raises US$10 million in a fully subscribed private placement to support manufacturing and regulatory filings for its Gamma-PN…

GPN Vaccines

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Ascletis Pharma Presents Preclinical Data for ASC48 and ASC37 at ObesityWeek

November 2, 2026 (8 days ago)

Ascletis Pharma showcases new preclinical data for its obesity pipeline, including the oral GIPR agonist ASC48 and the long-acting triple peptide agonist…

1672.HK

🌍 ASIA Read More →

🏢Release 📈 Stocks

Zhimeng Biopharma Completes Patient Enrollment for Phase 2/3 ALS Drug Trial

October 31, 2026 (10 days ago)

Zhimeng Biopharma advances its ALS treatment candidate CB03-154, completing patient enrollment for a pivotal Phase 2/3 clinical trial as it seeks to…

Zhimeng Biopharma

🌍 ASIA Read More →

🏢Release 📈 Stocks

Revolution Medicines and Medicilon Strengthen R&D Partnership in Shanghai

October 30, 2026 (11 days ago)

Revolution Medicines and Medicilon executives met at the Nanhui R&D center to discuss medicinal chemistry advancements, underscoring a strategic partnership between the…

RVMD 688202.SS

🌍 GLOBAL Read More →

📰News 🌐 Macro — 📊 Neutral

Global Seed Coating Market Projected to Reach $3.80 Billion by 2031

October 30, 2026 (11 days ago)

Driven by technological advancements in bio-based coatings and a need for uniform crop emergence, the seed coating industry expects steady 8.0% annual…

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Pelthos Therapeutics Merges With Castle Creek to Advance Rare Disease Pipeline

October 30, 2026 (11 days ago)

Pelthos Therapeutics and Castle Creek Biosciences combine forces to accelerate the development of a late-stage D-Fi franchise, aiming to address critical unmet…

Pelthos Therapeutics

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Femasys Appoints John Moorhead to Board Following August Private Placement

October 30, 2026 (11 days ago)

Biomedical firm Femasys adds former Seventh Generation CMO John Moorhead to its board, leveraging his extensive background in brand scaling and product…

FEMY

🌍 AMERICAS Read More →

🏢Release 🌐 Macro — 📊 Neutral

WPLab Researchers Explore Therapeutic Potential of Intestinal Worms

October 30, 2026 (11 days ago)

WPLab researchers publish findings on the therapeutic potential of intestinal worms, exploring their role in human health and microbiome restoration.

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Innovent Biologics Subsidiary Altruist Gains NMPA Approval for NDA Filing

October 29, 2026 (12 days ago)

Innovent Biologics subsidiary Altruist Biologics receives NMPA acceptance for a new drug application, validating its localized manufacturing platform and CDMO operational strategy.

01801.HK

🌍 ASIA Read More →

🏢Release 📈 Stocks

Asymchem Clears USFDA Inspection at Tianjin TIDES Facility

October 29, 2026 (12 days ago)

Asymchem Laboratories secures a critical regulatory win as its Tianjin TIDES facility passes the first USFDA Pre-Approval Inspection, bolstering the company's manufacturing…

002821.SZ

🌍 ASIA Read More →

🏢Release 📈 Stocks — 📊 Neutral

FDA Regulatory Strategy: Optimizing CGT Development Through Key Meetings

October 29, 2026 (12 days ago)

Industry experts detail how CGT sponsors can navigate the FDA regulatory landscape, utilizing specific meeting types to streamline development and ensure successful…

🌍 AMERICAS Read More →

🏢Release 📈 Stocks — 📊 Neutral

Diagonal Therapeutics Appoints Dr. Bender to Lead Strategic Pipeline Growth

October 29, 2026 (12 days ago)

Diagonal Therapeutics taps industry veteran Dr. Bender to drive therapeutic development and strategic pipeline expansion as the company enters a new phase…

🌍 AMERICAS Read More →